Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: Rationale for dapagliflozin administration for the prevention of adverse outcomes in patients with heart failure with reduced ejection fraction. Expert consensus statement

1. Comparison of Cardioprotective Effects of Dapagliflozin and Trimetazidine in the Model of Doxorubicin-Cyclophosphamide Cardiotoxicity

   Ashot Avagimyan, А. И. Трофименко, Mohammad Sheibani +11

   МақолаChemotherapy-induced cardiotoxicity and mitigationInnovative medicine of Kuban20231 иқтибос

   ABIABI:AkademIndex/openalex/2023.article.001614

2. Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 1)

   Ashot Avagimyan, Mohammad Sheibani, А. И. Трофименко +15

   МақолаDiabetes Treatment and ManagementInnovative medicine of Kuban20241 иқтибос

   ABIABI:AkademIndex/openalex/2024.article.001048